Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C11H16N2O.ClH |
| Molecular Weight | 228.718 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=CC=C(C=C1)N2CCNCC2
InChI
InChIKey=HFJDUYKRPHHPAX-UHFFFAOYSA-N
InChI=1S/C11H16N2O.ClH/c1-14-11-4-2-10(3-5-11)13-8-6-12-7-9-13;/h2-5,12H,6-9H2,1H3;1H
| Molecular Formula | C11H16N2O |
| Molecular Weight | 192.2575 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market. | 2001 Sep 15 |
|
| Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry. | 2003 Dec 25 |
|
| Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. | 2003 Jun |
|
| In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperazine (MeOPP) in rat and identification of the human cytochrome P450 enzymes responsible for the major metabolic step. | 2004 Feb |
|
| Metabolism of designer drugs of abuse. | 2005 Jun |
|
| The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. | 2007 Mar 22 |
|
| 4-(4-Methoxy-phen-yl)piperazin-1-ium chloride. | 2009 Feb 11 |
|
| Analysis of phenylpiperazine-like stimulants in human hair as trimethylsilyl derivatives by gas chromatography-mass spectrometry. | 2010 Oct 1 |
|
| Structure-dependent inhibition of the human α1β2γ2 GABAA receptor by piperazine derivatives: A novel mode of action. | 2015 Dec |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:08:35 GMT 2023
by
admin
on
Sat Dec 16 11:08:35 GMT 2023
|
| Record UNII |
ARJ7BR8SNG
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
3019718
Created by
admin on Sat Dec 16 11:08:35 GMT 2023 , Edited by admin on Sat Dec 16 11:08:35 GMT 2023
|
PRIMARY | |||
|
ARJ7BR8SNG
Created by
admin on Sat Dec 16 11:08:35 GMT 2023 , Edited by admin on Sat Dec 16 11:08:35 GMT 2023
|
PRIMARY | |||
|
71661
Created by
admin on Sat Dec 16 11:08:35 GMT 2023 , Edited by admin on Sat Dec 16 11:08:35 GMT 2023
|
PRIMARY | |||
|
254-166-6
Created by
admin on Sat Dec 16 11:08:35 GMT 2023 , Edited by admin on Sat Dec 16 11:08:35 GMT 2023
|
PRIMARY | |||
|
38869-47-5
Created by
admin on Sat Dec 16 11:08:35 GMT 2023 , Edited by admin on Sat Dec 16 11:08:35 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
|